CLAIRE BLOODWORTH: Open Payments
NPI 1043967441 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 6 payments from 5 companies in 2025. Trend: 2023 $941 · 2024 $408 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Celltrion USA Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Alexion Pharmaceuticals, Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $23 |
Products named: ZYMFENTRA, TREMFYA, ENTYVIO, OMVOH.
Industry payments across NY — which companies pay providers there.
